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1017-119 Cardiac Resynchronization Reverses Left Ventricular 
Remodeling and Reduces Cytokine Activation In 
Patients With Dilated Cardlomyopathy and Left Bundle 
Branch Block 
Luigi Padeletti, Mada Cristina Porciani, Andrea Colella, Paolo Pisragnoli, Alassandra 
Sabini, Nichola Musilli, Cdstina Tosti Guerro, Sergio Cavaglia, Susan Madden Vednsts, 
Kathryn E. Hilpisch, Francesco DeSeta, Michael R. Hill, Institute of Internal Medicine and 
Cardiology.. University of Florence, Florence, Italy, Medtronic, Inc., Minneapolis, 
Minnesota. 
In patients (pts.) with advanced heart failure (HF), dilated cardiomy0pathy (DCM) and left 
bundle branch block, cardiac rasynchronization (CR) and appropriate medical therapy 
improves patient HF symptoms, quality of life and ability to exercise. The purpose of this 
study was to evaluate the effect of CRT on cardiac structure, function and neurohor- 
mones. METHODS: Pts. with HF (NYHA II/III/IV), DCM (left ventdcular end diastolic 
dimension > 55 mm), and ventricular conduction abnormalities (QRS duration ~ 140 ms) 
ware implanted with an atdal-synchrounous, bi-ventdcular pacing system. Atrial-vsntricu- 
lar delay was optimised by Doppler echo (longest left ventdcular filling time and greatest 
cardiac output). NYHA class, QRS duration, six minute hall walk distance, quality of life 
score, achocardiogrom and plasma neurehormonas were evaluated at baseline and fol- 
lowing 3 mos. of therapy. RESULTS: 
N=25 pts. (22m, 71 ± 9 yrs.) Baseline 3 month p-value 
Patient Outcomes NYHA 2.68 ± 0.75 2.08 ± 0.83 < 0.001 
QRS duration (ms) 178 ± 29 148 ± 19 < 0.001 
6-Minute Hall Walk (m) 232 ± 163 317 ± 117 0.009 
QoL 38 ± 20 18 ± 16 <0.001 
Echocardiogrophy LVESVi 121.4 ± 51.1 f02.0 ± 52.1 0.032 
LVEF (%) 30.1 ± 7.6 37.1 ± 9.6 <0.001 
CI 2.03 ± 0.68 2.28 ± 0.56 0.012 
IVMD (ms) 41.2 ± 23.7 14.3 ± 10.9 0.001 
LV MPI 1.07 ± 0.53 0.79 ± 0.51 0.007 
Neurohormones IGF-1 (ng/ml) 96.7 ± 38.9 118.5 ± 43.6 0.012 
TNF-~ (pg/ml) 0.018 ± 0.010 0.017 ± 0.010 0,308 
sTNFR1 (ng/ml) 1.26 ± 0.49 1.19 ± 0.57 0.306 
sTNFR2 (ng/ml) 6.82 ± 2.65 5.98 ± 2.31 0,011 
Correlations were found between soluble TNF-(x R2 and QoL (r 2 = 0.166, p=0.048) and 
soluble TNF-(x R1 and LVEF (I .2 = 0.273, p--O.009). CONCLUSIONS: CRT improves pt. 
outcomes and appears to reverse some of the adverse effects of heart failure, related to 
cardiac structural changes and augmentation of the cytokine systems. 
1017-120 Reduction of Norepinephrine Levels With Biventricular 
Pacing but Recurrence of Arrhythmic Events In Patients 
With Blventrlcular-ICD and Cardiomyopathy 
Domanico Soaziani, Massimo Pagani, Gianfranco del Rosso, Stafano De Servi, Guido 
Grassi, Giuseppe Mancia, Legnano Hospital - Cardiology - EP lab., Legnano (Milan), 
Italy, University of Milan. Bicocca, Monza (Milan), Italy. 
It's known that CHF activates the sympathetic nervous system(SNS) and increases 
serum noropinephrine(NE)in direct proportion to severity of the disease.Emerging data 
support the use of bivantricular pacing(BP)in severe cardiomyopathy(CMP)with reduc- 
tion of NE levels in follow-up.However if it's real that BP is a promising modality for CHF 
with LBBB,it's not demonstrated the relation between deactivation of SNS with BP and 
arrhythmic events(AE)in idiopathic CMP.The aim of the study was to test if the reduction 
of NE after BP can produce a reduction of VT or VF in pts with idiopathic CMP.METH- 
ODS:we enrolled 43 with CMP, LBBB,normal coronary system,maximal medical ther- 
apy, spontaneous sustained vr  or VF(8pts underwent to ICD)without beta-blockers.We 
then randomized 20 pts to BP(Mecitronic Insync),15 pts to medical therapy and 8 pts to 
BP-ICD(Medtronic Insync-ICD),ln all pts we performed at baseline and after 12 weeks 
ejection frection,NE levels and ICD check at 4 and 12 weeks after implantation,All values 
ware expressed as mean ± standard deviation (SD). CONCLUSIONS:in 10ts with BP or 
BP-ICD we observed a significant improvement of EF and a marked reduction of SNS 
activation but all pta who underwent o BP-ICD have VT or VF in follow-up with correct 
shock by device;4 pts with BP get to sudden death after 4 months.Then we conclude that 
BP can decrease the NE levels but the deactivation of SNS can't reduce the rate of 
arrhythmic events in this kind of population and can't reduce the need of antitachycardia 
devices. 
SD(audden death);VT(ventrlcular tachlcardla);VF(ventrlcular fibrillation) 
NE(Basstine) NEl l2 wks) 
Group 1(28 pts:BP and BP-ICD ) 600 + 328 pg/ml p<0.05 330 ± 130 
Groupll(15pts:medical therapy) 570 + 302 pg/ml NS 605 ± 260 
AE(1-3 mth) AE(4-6 mth) 
Group 1(20pts:BP) 4 SD (20%) 
Group 11(8pts:BP-ICD) 6 V'I" and 2 SD (100%) 
Group 111(15pts: medical therapy ) I SD and 2 v'r (20%) 
JACC March 6, 2002 
POSTER SESSION 
1018 Implantable Cardioverter Defibrillator 
Therapy: Optimal Utilization 
Sunday, March 17, 2002, 9:00 a.m.-11:00 a.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 10:00 a.m.-11:00 a.m. 
1018-107 Performance of a Supraventrlcular Tachycardla 
Discrimination Algorithm by an Automatic External 
Cardioverter Defibrillator in Response to Induced 
Tachycardia 
Thomas A. Mattioni. David Riggio, Marwan Bahu, Sue Welch, Amber Rease, Nabil 
Kanaan, Don Lin, Arizona Heart Institute, Phoenix, Arizona, Cardiac Science, Inc., Irvine, 
Catifornia. 
Background: An algorithm with throe features (Modulation Domain Function, Wavaform 
Factor Analysis and Signal Variability Analysis) is used as a programmable option in an 
Automatic External Cardioverter Defibdllator (AECD) (Powerheart) to differentiate 
Supraventricular Tachycerdia (SVT) from vantdcular tachycardia or ventdcular fibrillation 
within a programmable SVT rate zone, The AECD will withhold therapy delivery in 
response to tachycardia that is recognized as SVT within that zone and recommend 
(advisory mode) or deliver therapy (active mode) for faster rates. 
Methods: Dudng routine diagnostic electrophysiology studies of 67 pts [Age: 61 yrs 
(Range 21-92), LVEF: 41% +/- 17%, Males: 39, Bundle Branch Block (BBB) 7 ], SVT was 
induced in 25 pts and the AECD then programmed with a detection rate that would result 
in this tachycardia being within the SVT zone, The advisory mode of the AECD was used 
to prevent actual therapy delivery. Bipolar right atdal pacing to mimic sinus tachycardia 
was also tested in an identical fashion in 55 pts. 
Results: A total of 31 clinical SVTs were induced [Atdal Tachycardia 8, Atrial Fibrillation 5, 
AV Reentry 10 and AV Nodal Reentry 8]. Rate detection was accurate in all episodes 
(Sensitivity 100 %), There were 25 True Negatives, 3 True Positives (episode rate 
exceeded the SVT zone), 3 False Positives (2 tachycardias with BBB, 1 inducible AV 
Nodal Reentry Techycardia with ST segment elevation). Of the 55 right atrial pacing epi- 
sodes there were 53 True Negatives and 2 False Positives (1 prolonged pacing PR inter- 
val with summation in the preceding QRS and 1 with BBB). (Specificity 94%). 
Conclusions: This AECD SVT discdmination algorithm functioned extremely well in 
response to a wide variety of tachycardias (particularly in the absence of BBB) and would 
be expected to very rarely result in inappropriate suppression of therapy delivery. 
1018-108 The Utility of Dual Chamber Electrogrem Recordings for 
the Diagnosis of Clinical Tachycardias 
Michael H. Kim, David Bruckman, Christian Sticheding, Frank Pelosi, Bradley P. Knight, 
Hakan Oral, Fred Morady, Adam Stdckberger, Evanston Northwestern Heaithcare, 
Evanston, Illinois, University of Michigan, Ann Arbor, Michigan. 
Background: The availability of the dual chamber defibrillator has allowed the assess- 
ment of device performance of various tachycardia discrimination algorithms, Vary little 
data, however, exist about the clinical interpretation of a tachycardia episode on the clini- 
cian level in regard to the utility of an atrial electrogram recording and its impact on the 
correct diagnosis and confidence of that diagnosis. Methods: Dual chamber defibrillator 
recordings (n--52) with a clear diagnosis were distributed in a blinded and randomized 
fashion to 5 electrophysiologists, initially with only the ventdcular data (Test V) and later 
with both the atrial and ventricular data (Test AV). The 52 matched pairs of recordings 
were analyzed with a McNemar's test to determine overall accuracy of diagnosis. 
Reviewer confidence in the diagnosis via a 5-point Likert scala was assessed with an 
analysis of variance, Logistic regression determined the relationship of confidence and 
diagnostic accuracy. Results: Overall accuracy for the specific diagnosis in Test V was 
60.8% and 79.2% in Test AV (p<0,001). Accuracy in defining the chamber of origin 
increased from 75.8% to 89.6% with the atdal data (p<0,001), Across all reviewers, con- 
fidence was significantly greater when the reviewer was correct. Overall mean confi- 
dence was greater in Test AV. The odds of a correct specific diagnosis were linearly 
related to greater confidence in both Test V and AV. Conclusions: The addition of the 
atdal stectrogrem allows for improved accuracy for both the specific tachycardis diagno- 
sis and the chamber of odgin. Clinician confidence was also enhanced and correlated 
with accuracy, Thus, the possibility of improved patient care through improved accuracy 
should be considered when evaluating a patient for a defibrillator. 
1018-109 A Prospective Analysis of Changes Stored Intrecardiac 
Electrogrem Morphologies After Implantable 
Cardloverter Defibrillators Shocks 
Frank Palosi. Jr., William Hsu, AI McCaulay, Radmira Greanstain, Aman Chugh, Sohail 
A. Hassan, Christoph Scharf, Hakan Oral, Bradley P. Knight, Fred Morady, S, Adam 
Strickberger, University of Michigan Health System, Ann Arbor, Michigan. 
Background: It is believed that analysis of stored intracardiac electrogroms after implant- 
able cardiovertar-defibdllator (ICD) shocks is unreliable because of distortions of the 
stectrogram morphology, though the duration and nature of these distortions is unknown. 
The objective of this study was to prospectively evaluate the effect of ICD shocks on 
stored intracardiac alectrogram morphology and identify variables that may affect these 
changes, Methods: Twenty-four patients (70%reals, 30% female) age 55±12 years 
undergoing prodischarge or outpatient defibdllation threshold determination received 4 
synchronized ICD shocks of 1, 11,21, 31 Joules (J) at 3-minute intervals. All intracardiac 
electrogroms were recorded from the shocking coils of a dual-coil ICD lead with inte- 
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grated bipolar sensing (Guidant, Inc., St. Paul, MN) and were digitally recorded to 
1000Hz then decimated to simulate the computation environment of an ICD. For each 
shock event, correlation waveform analysis was used to compare serial post-shock intra- 
cardiac electrogram against a baseline template created from the last 5 iotracardiac elec- 
trograms before the ICD shock. "nine to recovery to 90% of baseline was measured in 
each patient. ResultS: In the 24 patients studied, electrograms after 120 ICD shocks were 
analyzed. Nine patients (39%) had significant changes in electrogram morphology after 
an ICD shock. Time to recovery was 9.3±14.3sec after an 11J shock, 38.6±28.7sec after 
a 21J shock and 45.5±37.1 sec after a 31J shock. No changes in electrogram morphol- 
ogy were observed after a 1J shock. A direct corrstation existed between the delivered 
shock energy and the time to reversion of the intracardiac electrogram to the bassline 
tamplate(r=0.45, p=0.01). Patients receiving angiotensin-converting-enzyme (ACE) 
inhibitor therapy had less electrogram morphology distortions (16.7%) than those not tak- 
ing ACE inhibitors (63.6%, p=0.03). Conclusions: Delivered shock energy and ACE inhib- 
itor therapy can affect distortions in the stored intrecardiac electrogram morphology after 
ICD shocks. This suggests that physiologic factors play s significant role in the observed 
changes of stored electrogram recordings. 
1018-110 Outcome of a Device-Based Atrial Rhythm Control 
Strategy in Patients With Chronic Congestive Heart 
Failure and Diminished Ejection Fraction 
~ ,  Debra Housel, Srinivas Murali, AtrialArrhythmia Center, University 
of Pittsburgh, Pittsburgh, Pennsylvania. 
Background: We report an interim assessment of a "device-based" strategy for atrial 
rhythm control in patients with drug-refractory AF, chronic CHF and reduced left ventricu- 
lar EF (<40%). Methods: Each patient underwent implantation of a Medtronic Jewel AF 
(model 7250 device) system. This device incorporates atrial prevention/termination pac- 
ing and shock therapies. The device also provides bradycardia pacing and VT/VF thera- 
pies, The cohort consists of 32 patients (30 men; mean age 58 yrs; cause of reduced EF: 
ischemic [18], idiopathic [10], other [4]) with symptomatic, drug refractory AF, who have 
been followed for 246 +/- 196 days. Successful AF suppression was defined as AF bur- 
den <10% during followup. Results: Table shows mean(SD) values for pre-implant and 
latest followup (post-implant) in pts with successful AF suppression, which was achieved 
in 27 pts (84%), necessitating adjuvant antiarrhythmic drug therapy in 24 of these pts. 
There have been 8 deaths (all attributable to pump failure; 7 of 8 patients experienced AF 
suppression), 1 transplant and 1 ventricular assist device implantation. No device-related 
proarrhythmia was observed. Device therapy for previously undiagnosed VT/VF has 
occurred in 3 (9%) patients. Conclusions: during short-term followup, device-based atrial 
rhythm control in this population was feasible, safe, and associated with stable EF, IJVLV 
volumes, and NYHA class. Therapies for "new" VT/VF were not uncommon. 
Pre-lmplant Post-Implant 
EF (%) 30(10) 34(14) 
LV Volume (cc) 152(54) 186(68) 
LA Volume (cc) 148(53) 151 (43) 
NYHA Class 2.1 (0.9) 2.1 (1.0) 
1018-111 Importance of Avoiding Nominal Programming to 
Prevent Inappropriate Implantable Cardioverter 
Defibri l lator Shocks 
Andrea M. Russo, Henry Hsia, David Callans, Christa Schorr, Maureen Nicholas, Dusan 
Kocovic, Francis E. Marchlinski, University of Pennsylvania Health System, Philadelphia, 
Pennsylvania. 
Background: Prophylactic use of implantable cardioverter defibrillators (ICDs) raises 
increased awareness about the need to avoid inappropriate shocks for supraventricular 
arrhythmias (SVAs). 
Methods: Ninety-one pts without prior clinical sustained ventricular arrhythmias (VAs) 
received prophylactic ICDs; 46 pts presented with syncope and a dilated cardiomyopathy 
and 45 pts had no symptoms with coronary disease and inducible ventricular tachycardia 
(VT). During a follow-up of 21 +/o 18 months, 21 Lots (23%) experienced therapy for VAs 
and 13 pts (14%) for SVAs. We examined clinical VT and SVA rates. 
Results: Mean age was 60 +/- 15 yrs and LVEF 25 +/- 9%. Devices were programmed to 
a "single zone, shock only" configuration in 29 pts, with 2 zones in 5 pts, 
Only 2/21 pts (10%) had a clinical VT rate of < 190 bpm (both with inducible VT). The 
SVA suggested atrial fibrillation 8 pts, atrial tachycardia 3 pts, and sinus tachycardia 2 
pts. 
Conclusions: (1) Inappmpriata shock therapy occurs in 14% of pts receiving prophylactic 
ICDs during a short follow-up. (2) Despite availability of VT zones and detection 
enhancements, devices are frequently programmed to a "shock only" zone with a low 
rate cut-off. (3) Although there is some overlap between VT and SVA rates, VT rates are 
rarely <190 bpm in the absence of inducible VT. (4) Avoidance of programming to nomi- 
nal VF detection rates may prevent inappropriate shock therapy for SVAs. The potential 
role of programming a second zone with detection enhancements needs to be examined. 
*p value < 0,01, comparing clinical VT vs. SVA rates 
Rata(bpm) VF zone VT zone Clinical Clinical 
V'l" rate* SVA rate* 
N = 21 pts 13 pts 
Mean +/- SD 182 +/- 13 161 +/- 10 221 +/- 38 179 +/- 14 
Range 160 - 214 150 - 175 188 - 308 160 - 200 
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1019"112 The Evolution of Serial P Wave Signal-Averaged 
Electrocardiograms Fol lowing Direct Current 
Cardioversion of Atrial Fibril lation: A Prospective Study 
Xiao H. Guo, Jan Polonieki, Mark Gatlagher, Mohammad S. Harold, Yi Gang, Marak 
Malik, A. John Carom, St George's Hospital Medical School, London, United Kingdom. 
Background: The evolution of serial P wave signal-averaged ECG (P-SAECG) after DC 
cardioversion (DCC) of persistent atrial fibrillation (AF) was studied. Method: 60 pts 
underwent P-SAECG at regular intervals, 5 times over 6 months, Filtered P wave dura- 
tion (PD), root mean square voltage (RMS) of its terminal 40, 30, 20 ms, entire P wave 
and integral P wave were obtained using a FFT filter of 40-250 Hz with P wave triggered 
technique (GE, USA). Results: Of 60 pts (53 men, 66 ± 10 yrs), 31 (52%), 11 (18%), 2 
(3.3%), 2 (3.3%) pts returned to AF (RAF) in 0.25, 1, 3, 6 months respectively. There 
were no significant differences in age, sex, cardiac disease, AF duration, left atrial size 
between pts with and without RAF at 6 months. General linear model regression showed 
RAF group had prolonged PD (157 ± 24 vs 143 ± 17ms, p<0.0001) and lower RMS 40, 
30, 20 when compared with pts who maintained sinus rhythm (SR) ( 5.3±2,0 vs 6.1 ± 
3.4mV, p=0,007; 4.3 ± 1.5 vs 5.7 ± 3.2mV, p<0.0001; 3.6 ± 1.4 vs 5.2 ±3,0, p<0.0001 
respectively), these measurements did not change significantly over time in each out- 
come group. Only RMS-P and integral P evolved against time (Fig). In slope, the RMS-p 
in SR pts increased (p=0.009), whilst a reduction was noted in RAF pts (p=0,032) (differ- 
ence in slopes p=0,006). For integral-p, no change in SR group but in RAF slope was sig- 
nificantly decreased (p=0,0028), (difference in slopes p=0.0004). Conclusion: These 
differences in evolution suggest that returned AF is preceded by change in serial P- 
SAECG following DCC. 
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1019-113 Atrial Fibri l lation Recurrence: The Roles Of 
Hypertension, Duration Of Atrial Fibril lation, and 
Prolonged Signal-Averaged P Wave Duration 
Ulrik Dixen, Jan Parner, Vetoer Rasmussen, Staen M. Pehrson, Gorm B. Jansen, The 
University Hospital of Hvidovre, Copenhagen, Denmark. 
Background-Prolonged signal-averaged P wave duration (SAPD) has been established 
as a risk marker for atrial fibrillation (AF), We assessed the risk of hospitalization due to 
AF recurrence or transition to long-lasting AF in patients with earlier or present AF in rela- 
tion to the SAPD, clinical characteristics of the patients, and the duration of the AF dis- 
ease. 
Methods-In 111 consecutive patients (71/40 men/women; median age 65 years, range 
30-85 years) with eadier or present AF the SAPD was measured at inclusion, and the fol- 
low-up time was six months (median 184 days; range 171-437 days). Hospitalization due 
to AF recurrence or transition to tong-lasting AF were regarded as endpoints. 
Results-During the follow-up period 33 patients were hospitalized due to AF, and nine 
patients developed long-lasting AF, History of hypertension, OR=3.67 (95% CI 1.61 to 
8.37), duration of the AF disease longer than two years, OR=3.22 (95% CI 1.31 to 7.86), 
and non-significantly prolonged SAPD above 140 ms, OR=1,87 (95% CI 0,60 to 5.82) 
were related to an increased risk of hospitalization due to AF relapse or development of 
long-lasting AF, 
Conclusions-Hypertensive heart disease, duration of AF disease longer than 2 years, 
and prolonged SAPD above 140 ms were risk factors for AF relapse requiring hospital- 
ization or transition to long-lasting AF. The probability of recurrence in patients without 
risk factors was 9%, with one risk factor 16-27%, with two risk factors 37-54%, and with 
all three risk factors 74% (Table 1). 
Table 1: Probabilities of ftoapitallaation or transition to 
long-lasting AF from risk factors (%) 
No No Hypertension Hypertension 
hypertension hypertension 
SAPD < 140 ms > 140 ms < 140 ms > 140 ms 
Short duration of AF (< 2 9 16 27 47 
years) 
Long duration of AF (> 2 years) 24 37 54 74 
